Skip to main content
Equibles
LEGN logo

LEGN · Legend Biotech Corp

Track LEGN — free

Use LEGN with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about LEGN

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$20.37 +0.10 (+0.49%) At close · Aug 14
Market Cap
$3.95B
Shares
193.77M

Legend Biotech Corp Earnings Call Transcripts

Every quarterly earnings call for Legend Biotech Corp (LEGN) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Earnings call
FY26 · Q2
2026-08-11
Legend Biotech to Host Investor Conference Call on Second Quarter 2026 Results
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-12
Legend Biotech Corp Q1 FY2026 Earnings Call
Confident tone In Vivo cell therapy pipeline Earlier-line / frontline opportunity CARVYKTI commercial growth
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q3
2025-09-30
Legend Biotech Corp Q3 FY2025 Earnings Call
Confident tone ASH 2025 presentations Regulatory and label updates Manufacturing capacity expansion
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-06-30
Legend Biotech Corp Q2 FY2025 Earnings Call
Confident tone CARVYKTI commercial performance CARTITUDE clinical trials and frontline expansion FDA REMS removal and label update
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-03-31
Legend Biotech Corp Q1 FY2025 Earnings Call
Confident tone CARVYKTI commercial performance Earlier-line adoption and label expansion Manufacturing capacity and turnaround time
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2024-12-31
Legend Biotech Corp Q4 FY2024 Earnings Call
Confident tone CARVYKTI commercial launch and sales growth Manufacturing and capacity expansion ALC monitoring and risk mitigation
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-09-30
Legend Biotech Corp Q3 FY2024 Earnings Call
Confident tone CARVYKTI commercial sales growth Overall survival benefit / CARTITUDE-4 Geographic expansion (OUS)
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-03-31
Legend Biotech Corp Q1 FY2024 Earnings Call
Confident tone Commercial launch and demand growth Manufacturing capacity expansion and supply CARVYKTI regulatory approvals and label expansion
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
Legend Biotech Corp Q4 FY2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-09-30
Legend Biotech Corp Q3 FY2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-06-30
Legend Biotech Corp Q2 FY2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2020-12-31
Legend Biotech Corp Q4 FY2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Showing 1–12 of 12 earnings calls
Key facts CIK 1801198 CUSIP 52490G102 13F (30d) 222 filings 208 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)